Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome

S

St. Petersburg State Pavlov Medical University

Status

Completed

Conditions

Lamotrigine
Memnatine
Topiramate
Diazepam
Placebo

Treatments

Drug: Anticonvulsants

Study type

Interventional

Funder types

Other

Identifiers

NCT00241995
RCT-RCT_LOND_GAT_AWS_2003

Details and patient eligibility

About

The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate, lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome

Sex

All

Ages

20 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Alcohol dependence Alcohol withdrawal syndrome

Exclusion criteria

Drug dependence Major psychiatric diagnoses Severe somatic illness

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems